Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

BACKGROUND: Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing severe lower respiratory tract infection (LR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pediatr
Autors principals: de Souza, Roseane Porfírio, Ribeiro, Andre Luis Ribeiro, de Menezes, Sílvio Augusto Fernandes, Machado, Luiz Fernando Almeida
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714430/
https://ncbi.nlm.nih.gov/pubmed/31462289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-019-1681-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars